598 results on '"Wu J"'
Search Results
2. RWD132 Impact of Exacerbations on Disease Burden of COPD: A Retrospective Observational Database Cohort Study in Tianjin, China
3. CO121 Treat-and-Extend Versus As-Needed Regimen in Neovascular Age-Related Macular Degeneration: 1-Year Findings From a Network Meta-Analysis
4. HPR70 Developing the Risk-Adjusted Capitation Payment for Patients With Diabetes Mellitus in China: Results From Administrative Data in Tianjin
5. HPR182 What Impact Did China's National Volume-Based Procurement Have on Drug Use Pattern and Clinical Benefit? Taking Amlodipine as an Example
6. RWD19 Real-World Disease Burden of Chronic Obstructive Pulmonary Disease: A Retrospective Population-Based Cohort Study in Tianjin, China
7. MSR85 Performance Comparison of Unanchored Matching-Adjusted Indirect Comparison and Naïve Treatment Indirect Comparison on Survival Outcomes: A Simulation Study
8. PCR125 Perceived Communication with Physicians Among Older Patients with Multiple Chronic Conditions and Associated Racial Disparities
9. EPH153 A Population-Based Study of the Epidemiology, Healthcare Resource Utilization and Costs of Duchenne Muscular Dystrophy in Alberta, Canada
10. PCR97 Discrete Choice Experiment Vs. Best-Worst Scaling: An Empirical Comparison in Measuring Treatment Preference of Lung Cancer Patients
11. RWD60 Real-World Dispensing of Buprenorphine and Methadone from MAR 2019 to MAR 2021 in California
12. CO76 Hypertension and the Risk of Dementia Among Medicare Beneficiaries in the U.S.
13. RWD177 Treatment Pattern and Disease Burden of Severe Asthma: A Real-World Study Based on Claims Data in China
14. PCR207 Health-Related Quality of Life and Its Associate Factors Among Residents in Tianjin, China: Findings from 2023 National Health Service Survey
15. PCR175 Screening for Anxiety and Depressive Symptoms in Adolescents With Complex Health Conditions From a Longitudinal Registry Study in Los Angeles County: Comparative Performance of the EQ-5D-5L and PedsQL
16. RWD97 Real-World Disease Burden of Fibrodysplasia Ossificans Progressiva in China
17. RWD98 Real-World Management of Prurigo Nodularis: Epidemiological and Comorbidity Data in China
18. PCR43 Health Utility Decrement of Injection Treatment-Related Attributes Among Type 2 Diabetes Patients in China
19. HPR13 A County-Level Deprivation Index for China in 2020 and Its Association With Life Expectancy and Infant Mortality
20. EPH135 Impact of Demographics and Social Determinants of Health on Hospitalization Costs in US Adults With Respiratory Syncytial Virus
21. EPH70 Real-World Second-Line Treatment Pattern and Disease Burden of Patients With Unresectable or Advanced Hepatic Carcinoma in China: A Retrospective Database Study
22. POSA379 Differences in Cancer Treatment Preferences Among Oncologists, Patients and Family Members: A Discrete Choice Experiment
23. POSC396 Real-World Treatment Pattern and Direct Medical Costs of Atopic Dermatitis in China: A Retrospective Claims Database Analysis
24. POSB242 Telemedicine Use During Year 2020 of the COVID-19 Pandemic in Older US Medicare Beneficiaries
25. POSB362 Measuring Patient Preferences: Comparison of Five Discrete Choice Modeling Methods
26. POSB56 Cost-Effectiveness of Satralizumab Compared to Eculizumab for the Treatment Neuromyelitis Optica Spectrum Disorders (NMOSD) in Adult and Adolescent Patients Who Are Anti-Aquaporin 4 (AQP4) Seropositive in Canada
27. PND39 Socioeconomic Value of Ocrelizumab in the Treatment of Patients with Relapsing Remitting Multiple Sclerosis
28. PMU16 Hospital Outcomes Attributable to Congestive Heart Failure in Patients with Endometrial Cancer in the U.S.: A Retrospective Analysis
29. PDG25 The Impact of Cost Related Medication Nonadherence on Healthcare Utilization and Patient-reported Outcomes among Elderly Medicare Beneficiaries on Antidepressants
30. PND50 Patterns of Home Health Care Use and Associated Costs in Elderly with Alzheimer's Disease and Related Dementias
31. PMH33 Cost-Utility Analysis of Lurasidone for the Treatment of Schizophrenia in China
32. PNS99 Using an Online Survey to Elicit Preferences in China: Comparison of Different Methods Based on SF-6DV2
33. PNS100 Comparison of Test-Rest Reliability of Cardinal and Ordinal Preference Elicitation Methods
34. PRO66 Health-Related Quality of Life in Persons with Sickle Cell Disease
35. PND16 Socioeconomic Value of Ocrelizumab in the Treatment of Patients with Primary Progressive Multiple Sclerosis
36. PDG38 Association between Satisfaction with Quality of Care and ANTI-Dementia Medication Adherence Among Elderly Adults with Alzheimer's Disease and Related Dementias
37. PUK23 The Impact of Hyperkalemia on Survival and Healthcare Resource Utilization Among Patients with Chronic Kidney Disease in China
38. PCR4 A Targeted Literature Review of Disutilites for Type 2 Diabetes Treatment-Related Attributes
39. HPR51 Should Volume-Based Procurement Price of Comparator be Referenced for Innovative Drugs in National Reimbursement Drug List Negotiation in China?
40. PNS248 A Hierarchical Bayes Approach in Exploring Individual Heterogeneity: An Application on Health State Valuation Using a Discrete Choice Experiment
41. PDB23 EXLORATION IN HEALTHCARE RESOURCE UTILIZATION (HCRU) STUDY USING EMR DATABASE AND CLAIMS DATA
42. PDB31 DIRECT MEDICAL COSTS OF INCIDENT COMPLICATIONS IN PATIENTS WITH NEWLY-DIAGNOSED TYPE 2 DIABETES IN CHINA: FINDINGS FROM A MEDICAL CLAIMS DATABASE
43. PP3 VALUATION OF SF-6DV2 HEALTH STATES USING TIME TRADE-OFF AND DISCRETE CHOICE EXPERIMENT WITH DURATION APPROACHES IN CHINA
44. PIH63 THE EFFICACY OF TREATMENTS FOR ATOPIC DERMATITIS IN CHILDREN: A NETWORK META-ANALYSIS
45. PCV34 MEDICATION USE, HEALTH CARE RESOURCE USE AND DIRECT MEDICAL COSTS FOR PATIENTS WITH VERY-HIGH-RISK ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN CHINA
46. PMH41 ASSOCIATION BETWEEN FINANCIAL ACCESS BARRIERS TO HEALTH CARE AND QUALITY OF LIFE AMONG PATIENTS WITH COGNITIVE IMPAIRMENT
47. PNS191 TEST-RETEST RELIABILITY OF COMPOSITE TTO AND DCE WITH DURATION IN THE VALUATION OF SF-6DV2 HEALTH STATES
48. PMS10 MEDICATION USE, CLINICAL OUTCOMES AND ECONOMIC BURDEN AMONG PATIENTS WITH PREVALENT OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN IN CHINA: A CROSS-SECTIONAL STUDY BASED ON CLAIMS DATABASE
49. PDB83 THE ROLE OF HEALTH CARE PROVIDER'S ADVICE IN PREDIABETES MANAGEMENT IN THE US
50. RE3 TRENDS IN AND EFFECTS OF HIGH DEDUCTIBLE HEALTH PLAN (HDHP) AMONG PATIENTS WITH COGNITIVE IMPAIRMENT
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.